Squarepoint’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.78M Sell
41,200
-144,300
-78% -$12.6M ﹤0.01% 1810
2026
Q1
$15.8M Sell
185,500
-12,400
-6% -$1.11M 0.02% 819
2025
Q4
$15.6M Sell
197,900
-70,700
-26% -$5.54M 0.02% 859
2025
Q3
$21.5M Buy
268,600
+68,300
+34% +$5.83M 0.02% 705
2025
Q2
$18.2M Buy
200,300
+131,900
+193% +$12M 0.02% 806
2025
Q1
$6.41M Sell
68,400
-194,100
-74% -$17.4M 0.01% 1283
2024
Q4
$23.9M Buy
262,500
+112,800
+75% +$10.8M 0.02% 684
2024
Q3
$15.5M Sell
149,700
-37,000
-20% -$3.77M 0.02% 715
2024
Q2
$18.1M Buy
186,700
+5,800
+3% +$535K 0.03% 633
2024
Q1
$16.3M Buy
180,900
+75,900
+72% +$6.43M 0.03% 711
2023
Q4
$8.37M Buy
105,000
+58,900
+128% +$4.43M 0.02% 1048
2023
Q3
$3.28M Sell
46,100
-44,600
-49% -$3.33M 0.01% 1456
2023
Q2
$6.99M Buy
90,700
+75,000
+478% +$5.81M 0.02% 887
2023
Q1
$1.18M Buy
+15,700
New +$1.17M ﹤0.01% 1784
2021
Q1
Sell
-22,200
Closed -$1.9M 3170
2020
Q4
$1.9M Buy
+22,200
New +$1.84M 0.01% 962

Other funds holding CL

Squarepoint's CL Position: Q2 2026 in Review

Squarepoint increased its Colgate-Palmolive (CL) stake by 476% in Q2 2026, buying an estimated $8.92M and bringing the position to 123,417 shares worth $11.3M. The position accounts for 0.01% of the portfolio, ranked #1032.

Squarepoint first reported a position in CL in Q4 2015 and has held it in 39 quarters since. The position peaked at $116M in Q4 2023. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Squarepoint held 123,417 shares of Colgate-Palmolive worth $11.3M as of Q2 2026.
  • Squarepoint bought 101,990 Colgate-Palmolive shares in Q2 2026, an estimated $8.92M.
  • Colgate-Palmolive made up 0.01% of Squarepoint's portfolio in Q2 2026, its #1032 holding.
  • Squarepoint first reported a position in Colgate-Palmolive in Q4 2015 and has held it in 39 quarters since.
  • Squarepoint's Colgate-Palmolive position peaked at $116M in Q4 2023.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.